Program Implementation
Funding
This section provides potential funding opportunities and modalities to cover the costs of MOUD (also referred to as MAT) for pregnant patients in jail – things like where to find funding to run a program, what will impact costs, and resources to support estimating and acquiring funding. While MOMCARE is geared toward serving pregnant patients with OUD, many of these funding considerations apply to non-pregnant patients in custody as well.
HOW
Action Items
- Consult with your contracted health provider (if applicable) to discuss MOUD being in the request for proposals (RFP) and having at least buprenorphine on the formulary. See sample contractual language used for incorporating MOUD services into medical provider RFPs.
- Use the Correctional Health Care RFP Toolkit to assist you with preparing, drafting, issuing, evaluating, and negotiating RFPs for correctional healthcare services.
- Contact your local health department for possible funding and collaboration opportunities for MOUD. Find out if your state has received opioid abatement funds from pharmaceutical company settlements to be used towards overdose reduction programs.
- Determine what MOUD delivery model is best for your facility. The model will directly impact There are pros and cons to each.
- Assess what medications are available in the surrounding community (accessible to your facility and the public). Evidence-based MOUD involves making multiple forms of medication available and promotes shared decision-making between the patient and provider.
- Find out whether your state has been awarded opioid response grants, and if so, what they are. This can help fund MOUD treatment and training for staff in corrections settings.
Estimating costs
Each jail must first determine what MOUD delivery model is feasible and appropriate for their setting. Administrators should consider the following when determining the delivery model: staffing capacity to get daily MOUD doses to patients, staffing expertise in OUD and pregnancy care, health care delivery models and contracts, and community infrastructure. The type of medications your jail makes available will impact cost, as each formulation and delivery method vary. We recommend making both methadone and buprenorphine available. Methadone is often the least expensive. Extended-release injectables like naltrexone and Sublocade are often the most expensive, but these are not recommended in pregnancy.
Please see the Implementation – MOUD delivery – Delivery models for information describing the different modalities of delivering MOUD to people in jail custody.
Tools to help you estimate what the costs will be for your jail to have MOUD:
- CHERISH Research Budget Impact tool (excel)
- Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities – Explanation of tool creation and use
- The tool helps decide which model is most feasible based on facility, not the best overall
- The tool does not heavily account for contingencies, like 300% increase in demand or DOJ audit (but you can request consultation from the creators if needed)
- Webinar- Budget Impact Tool to Help Estimate Costs of Providing Medications to Treat Opioid Use Disorder in Jails/Prisons (JCOIN)
- Franklin County Jail Buprenorphine/Naloxone MAT Program Budget Calculator
Identifying funding opportunities
Jails fund MOUD in many different ways ranging from local, state, and federal grants and support. We first suggest finding out whether your state has applied and been approved for a Medicaid Reentry Section 1115 Demonstration Waiver to cover health care costs, including MOUD, for services provided in custody between 30-90 days pre-release. Then, you should look at whether your state has been awarded opioid response grants and what they are. Jails may be able to get discounted rates on MOUD through state block grants, Federally Qualified Health Centers (FQHCs), or subsidized medication programs. Use the table below to learn more details on possible funding options.
Name of Funding (with link) |
Description |
|---|---|
|
Medicaid Section 1115 Waivers
BJA webinar: Navigating the New Medicaid Section 1115 Demonstration Opportunity |
Medicaid will not pay for ongoing health services for people in custody, but states can apply for a Section 1115 Waiver that will allow Medicaid to pay for health care costs, potentially including MOUD, for people in jail 30-90 days pre-release. The waiver is dually beneficial since it offsets some costs from the jail and ensures the patient has coverage at reentry. If your state has applied and been approved for a waiver, then you can enroll patients in Medicaid while they are in jail, and it will cover health care costs for them! This website can tell you if your state has an approved 1115 Waiver that covers incarcerated people. |
|
SAMHSA State Targeted Response to the Opioid Crisis Grants (STR) |
Intended to close the treatment gap between those who seek treatment and those who receive it. At least 80% of the award must fund treatment services and may be used for services in corrections settings and for reentry.1 |
|
$1 billion grant program with 15% set aside for the states with the highest rates of drug overdose deaths. Grants can be used for services including treatment and training for staff in corrections settings and for reentry. 1 |
|
|
Comprehensive Opioid, Stimulant, and Substance Abuse Program (COSSAP) |
The COSSAP grant program is awarded to state, local, and tribal entities to support responses to the opioid epidemic to reduce overdose deaths, promote public safety, and support access to treatment and recovery services in the criminal justice system, including in correctional facilities. 1 |
|
The RSAT for State Prisoners Program assists states, local, and tribal governments in the development and implementation of substance abuse treatment programs in state, local, and tribal correctional and detention facilities. Funds are also available to create and maintain community reintegration services for individuals after they are released from incarceration. 1 |
|
|
SAMHSA Block Grants SAMHSA funds states and territories through the following grants: |
Block grants are used to supplement Medicaid, Medicare, and private insurance to provide access to prevention, treatment, recovery supports, and other services. Grant funds are awarded to the state behavioral health authority, substance abuse authority, and/or mental health authority, depending on how the state agencies are arranged.1 |
|
Allows certain entities that serve large uninsured patients to obtain drugs from pharmaceutical supplies at the same discounted rates that Medicaid pays (i.e. 25-50% less).2 |
|
|
FQHCs are located in inner cities and rural areas and serve uninsured and low-income individuals. Many offer Buprenorphine based on discounted fees. 2 |
1 Expanding Access to Medications for Opioid Use Disorder in Corrections and Community Settings: A Roadmap for States to Reduce Opioid Use Disorder for People in the Justice System. (Washington, D.C.: National Governors Association and American Correctional Association, January 2021).
2 Jail-based Medication-Assisted Treatment: Promising Practices, Guidelines, and Resources for the Field. (National Sheriff’s Association and National Commission on Correctional Health Care, October 2018)
WHY
A successful and comprehensive MOUD program for pregnant individuals is dependent on being able to pay for the medications, staffing, and training required to run it. Addressing funding will help you plan for your program’s capacity, scope, and sustainability.
- Medicaid Section 1115 Waiver
- Expanding Access to Medications for Opioid Use Disorder in Corrections and Community Settings: A Roadmap for States to Reduce Opioid Use Disorder for People in the Justice System (American Correctional Association & National Governors Association, Feb. 2021)
- Funding, Delivery and Payment (p. 44-46)
- Medicaid State Plan, Waiver, and Managed Care Options (p.46-51)
- Appendix B: Additional Readings on Medicaid and Justice-Involved Populations (p. 57-58)
- Medication Assisted Treatment for Opioid Use Disorders in Jails and Prisons: An Implementation Toolkit (Vital Strategies & National Council for Behavioral Health, 2023)
- Identifying Funding Sources (p.87-88)
- Appendix A: Resources & Guides – Component 7: Funding & Sustainability (p.99)
- Bureau of Justice Statistics funding opportunities
- Use the Correctional Health Care RFP Toolkit to assist you with preparing, drafting, issuing, evaluating, and negotiating RFPs for correctional healthcare services.
Policies and Procedures 🤰
This section highlights the importance of having an official jail policy and protocol for pregnant and postpartum patients at your jail, including those who use opioids. This section describes key things that the policy should include.
HOW
Action Items
- Use the MOMCARE Preparing a Model Jail Pregnancy Policy Checklist to assess your jail’s current pregnancy policy

- Create a plan of how to address items flagged as ‘insufficient, missing, and unsure.’ This may include adding more details to the policy or developing new procedures.
- Once the policy is revised, disseminate it to all staff and bring special attention to newly added or updated content. Consider reviewing the policy reviewing the policy during in-service training or designated team meetings to ensure all staff are informed.
- When a pregnant patient enters custody, reorient medical and custody staff to your policy including when to transport a pregnant patient to the hospital. Host weekly multidisciplinary meetings with staff from medical, custody, behavioral health, etc., to discuss updates on pregnant and postpartum patients in custody.
- If policies and protocols are not being followed, leadership should discuss options for reinforcement (g. post visual 1-pagers, individual check-in meetings, etc.)
- Update (and announce/educate) the policy as needed including addressing any identified gaps, changes in services, and contact persons listed. Policies should be reviewed at least every 6 months.
Policies and protocols should be detailed and thorough. They direct staff what to do, when to do it, who is involved, and where to go (or who to contact) for additional services and support. Including information on outside entities (e.g. local hospital, opioid treatment provider, and prenatal care provider) in your protocols will also help foster relationships between the jail and the community, making it easier to coordinate care.
Your jail’s policy for pregnant and postpartum individuals in custody should be informed by national guidelines and standards on perinatal care, correctional health, and substance use disorder treatment. Organizations that publish such national guidance include (but are not limited to) the American College of Obstetricians and Gynecologists (ACOG), the National Commission on Correctional Healthcare (NCCHC), the American Correctional Association (ACA), the American Society of Addiction Medicine (ASAM), and Substance Abuse and Mental Health Administration (SAMHSA).
Use the MOMCARE Preparing a Model Jail Pregnancy Policy Checklist to get a better understanding of what a robust, comprehensive policy for pregnant and postpartum individuals with OUD should entail and to assess your jail’s current policy.
All procedures in the policy should follow the SMART principles:
| Specific | Does the directive clearly state what needs to be done to address the issue and/or provide care? |
| Measurable | How should jail staff document that the procedure was performed? |
| Achievable | Do jail staff have the support and resources they need to accomplish the procedures? |
| Relevant | Do the procedures align with the national standards, the needs of the patients, and the values of the jail? |
| Time-bound | Does the procedure indicate when (and how often) it should be completed/performed? |
WHY
Having an official jail policy for pregnant and postpartum patients in custody, including those with OUD, promotes a standardized approach to treatment and suggests readiness to provide care. The policy can serve as a reference and resource for medical and custody staff on what to do when a pregnant or postpartum individual with OUD enters and leaves custody and will keep staff accountable. Creating or enhancing your jail’s policy for pregnant patients with OUD will also foster a thoughtful approach and coordinated care if challenges arise when caring for this population. From a risk management perspective, a detailed policy can help protect the health of your pregnant patients and decrease the chances of non-standard care, which can prevent possible litigation.
- MOMCARE Preparing a Model Jail Pregnancy Policy Checklist
- Position statements and guidelines
-
- Opioid Use Disorder Treatment in Correctional Settings – National Commission on Correctional Health Care (NCCHC)
- Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings: Evidenced-base Resource Guide Series – Substance Abuse and Mental Health Services Administration (SAMHSA)
- National Sheriff’s Association Supports the Use of FDA-Approved and Evidenced-Based Medication Assisted Treatment (MAT) for Opioid Use Disorder in County Jails
- Joint Public Correctional Policy on the Treatment of Opioid Use Disorders for Justice-Involved Individuals – American Correctional Association (ACA) & American Society of Addiction Medicine (ASAM)
- Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit – Vital Strategies and The National Council for Behavioral Health
- Appendix G: Samples Policies and Forms (p.111)
- Medications for Opioid Use Disorder (MOUD): Correctional Health Implementation Toolkit – New York State Department of Health
- Buprenorphine distribution policy and procedure (p.47, Appendix A)
- Buprenorphine initiation protocol (p.57, Appendix C)
- Guidelines for Managing Substance Withdrawal in Jails – Newly developed toolkit on substance withdrawal management instructions and care guidance (including opioids) for Local Government Officials, Jail Administrators, Correctional Officers, and Health Care Professionals.
- Each section has pregnancy and postpartum-specific information
- Urgent Maternal Warning Signs – information on urgent maternal warning signs to look out for and includes 1-page flyers in 14 languages
Memorandum of Understanding (MOU)
This section introduces the importance of using a memorandum of understanding (MOU) when forming partnerships between the jail and other entities that provide services to pregnant and postpartum patients and those with OUD.
HOW
If you are working with an outside entity to provide care to pregnant (and other) patients in custody, consider implementing an MOU.
Action Items
- Identify the organization, a point person, and the services provided to your facility/incarcerated persons.
- Request a meeting with the point person to discuss using an MOU to outline your arrangement, goals, responsibilities, and terms of your agreement.
- Draft and review the MOU so that both parties are satisfied with the terms. Revise as necessary. See example MOUs on the resources tab.
- Consult each organization’s legal team (if applicable) for final review before signing.
There are some key elements that every MOU should encompass:
- Title
- Names of the organizations involved
- Timeline and length of the agreement
- Context and purpose of the agreement
- Scope and objectives
- Terms of agreement and responsibilities of each involved party
- Confidentiality clause
- Conflict resolution clause
- When and how involved parties can end the agreement
- Signatures of all parties involved
WHY
A memorandum of understanding (MOU) is an agreement between two or more parties that clearly defines how the entities will work together and outlines shared expectations and responsibilities. It is used to achieve mutual understanding of the partnership and shared goals that each party feels confident about. Some benefits of using a MOU include establishing a common intention, formulating clear objectives, reducing uncertainty in who does what, ease of dissolving the partnership, and leaving a paper trail on record. Unlike a contract or memorandum of agreement (MOA), a MOU is not legally binding but should be taken as a serious declaration and you may want the jail’s legal team to review it.
For pregnant patients with OUD in custody, some partnerships may include the vendor used to provide MOUD like a community opioid treatment provider (OTP), or a community-based prenatal care provider.



